Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ)
300181.SZ Stock Price Chart
Explore Zhejiang Jolly Pharmaceutical Co.,LTD interactive price chart. Choose custom timeframes to analyze 300181.SZ price movements and trends.
300181.SZ Company Profile
Discover essential business fundamentals and corporate details for Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
22 Feb 2011
Employees
2.69K
Website
https://www.zuoli.comCEO
Tao Wang
Description
Zhejiang Jolly Pharmaceutical Co., Ltd. engages in the research, production, and marketing of Chinese medicinal products in China and internationally. The company offers Wuling capsule that is used to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. It also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, and soreness and weakness of waist and knees caused by benign prostatic hyperplasia, kidney deficiency, and blood stasis; and Bailing tablet that is used as the adjuvant therapy to treat cough, asthma, back pain, and chronic bronchitis, which are caused by the deficiency of lungs and kidney. In addition, the company offers Linglianhua particles for the treatment of symptoms, including sweating, insomnia, dysphoria, heart palpitations, dreaminess, giddy tinnitus, lassitude in loin and legs, dry stool, and abnormal furred tongue, as well as weak pulse caused by perimenopausal syndrome, or disharmony of heart and kidney. Further, it provides azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside injections. Additionally, the company offers materials, such as cordyceps cephalosporium, fermented cordyceps, and Wuling powders. It also invests and participates in the medical services of Deqing No.3 People's Hospital. The company was formerly known as Zhejiang Jolly Pharmaceutical Health Products Co., LTD. and changed its name to Zhejiang Jolly Pharmaceutical Co., Ltd. in 1998. Zhejiang Jolly Pharmaceutical Co., Ltd. was founded in 2000 and is based in Huzhou, China.
300181.SZ Financial Timeline
Browse a chronological timeline of Zhejiang Jolly Pharmaceutical Co.,LTD corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 24 Apr 2025
EPS came in at ¥0.26, while revenue for the quarter reached ¥824.43M.
Earnings released on 9 Mar 2025
EPS came in at ¥0.12, while revenue for the quarter reached ¥533.00M.
Earnings released on 27 Oct 2024
EPS came in at ¥0.18, while revenue for the quarter reached ¥616.62M.
Earnings released on 29 Jul 2024
EPS came in at ¥0.22, while revenue for the quarter reached ¥744.29M.
Dividend declared on 22 May 2024
A dividend of ¥0.45 per share was announced, adjusted to ¥0.45. The dividend was paid on 22 May 2024.
Earnings released on 18 Apr 2024
EPS came in at ¥0.20, while revenue for the quarter reached ¥672.90M.
Earnings released on 11 Mar 2024
EPS came in at ¥0.14, while revenue for the quarter reached ¥477.55M.
Earnings released on 22 Oct 2023
EPS came in at ¥0.13, while revenue for the quarter reached ¥453.49M.
Earnings released on 9 Aug 2023
EPS came in at ¥0.14, while revenue for the quarter reached ¥515.76M.
Dividend declared on 30 May 2023
A dividend of ¥0.30 per share was announced, adjusted to ¥0.30. The dividend was paid on 30 May 2023.
Earnings released on 25 Apr 2023
EPS came in at ¥0.14, while revenue for the quarter reached ¥495.70M.
Earnings released on 14 Mar 2023
EPS came in at ¥0.11, while revenue for the quarter reached ¥460.75M.
Earnings released on 25 Oct 2022
EPS came in at ¥0.11, while revenue for the quarter reached ¥449.45M.
Earnings released on 30 Aug 2022
EPS came in at ¥0.11, while revenue for the quarter reached ¥455.53M.
Dividend declared on 31 May 2022
A dividend of ¥0.20 per share was announced, adjusted to ¥0.20. The dividend was paid on 31 May 2022.
Earnings released on 20 Apr 2022
EPS came in at ¥0.11, while revenue for the quarter reached ¥439.42M.
Earnings released on 10 Mar 2022
EPS came in at ¥0.08, while revenue for the quarter reached ¥378.93M.
Earnings released on 26 Oct 2021
EPS came in at ¥0.07, while revenue for the quarter reached ¥380.80M.
Earnings released on 28 Jul 2021
EPS came in at ¥0.07, while revenue for the quarter reached ¥357.52M.
Dividend declared on 31 May 2021
A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 31 May 2021.
Earnings released on 27 Apr 2021
EPS came in at ¥0.07, while revenue for the quarter reached ¥340.16M, missing expectations by -86.58%.
Earnings released on 10 Mar 2021
EPS came in at ¥0.04, while revenue for the quarter reached ¥321.33M.
Earnings released on 30 Oct 2020
EPS came in at ¥0.05, while revenue for the quarter reached ¥302.76M.
Earnings released on 31 Jul 2020
EPS came in at ¥0.03, while revenue for the quarter reached ¥273.60M.
300181.SZ Stock Performance
Access detailed 300181.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.